Health in 2 Point 00, Episode 165 | Centene, Koa Health, Eko and Medically Home
Today on Health in 2 Point 00, there is so much to talk about between the election, the Affordable Care Act, and Pfizer’s COVID vaccine news. On Episode 165, we talk about how this is impacting the markets and cover more deals. ACA darling Centene has acquired Apixio, Koa Health spins out from Telefónica and gets $16.5M in initial funding, Eko raises $65 million in a Series C for their connected stethoscope and ECG, and Medically Home raises $40 million in another continuous clinic play, bringing their total to $65 million. —Matthew Holt (Source: The Health Care Blog)
Source: The Health Care Blog - November 10, 2020 Category: Consumer Health News Authors: Christina Liu Tags: Health in 2 Point 00 Health Tech Health Technology Jessica DaMassa Matthew Holt Apixio Centene Eko Koa Health Medically Home Source Type: blogs
The vaccine
Massive excitement as Pfizer announces it ' s mRNA vaccine is " 90% effective " against the virus that causes Covid-19. That has Pfizer ' s stock soaring and the media heralding a " breakthrough. " This isprobablysome degree of good news but the jubilee is very premature. First, although Pfizer has not been transparent about details of the ongoing clinical trial, they have not yet even met the required sample size to consider the estimate of efficacy reliable. They also have not said exactly what the endpoint is -- as I noted in a previous post, most trials apparently assess the incidence of symptomatic infectio...
Source: Stayin' Alive - November 10, 2020 Category: American Health Source Type: blogs
Vaccine Music To Libertarian Ears
Ryan BourneRonald Reagan once said,“There is no limit to the amount of good you can do if you don’t care who gets the credit.” In the U.S.’s fraught political climate, sadly it was predictable that even the welcome news of Pfizer’s promising COVID-19 trial results would produce a political dogfight about the timing of the announcement and who should be thanked for the prospect of the pandemic ending sooner.Vice President Mike Pence, for example, tweeted this morning: “HUGE NEWS: Thanks to the public‐private partnership forged by President@realDonaldTrump,@pfizer announced its Coronavirus Vaccine trial...
Source: Cato-at-liberty - November 9, 2020 Category: American Health Authors: Ryan Bourne Source Type: blogs
THCB Book Club, October: Mike Magee, Code Blue
Dr. Mike Magee has spent his life inside the medical-industrial complex, eventually working at Pennsylvania Hospital and later becoming the doctor who sold Viagra to the world at Pfizer. He’s also an award winning medical broadcaster and historian who appears regularly on THCB these days. For the October THCB Book Club Jessica DaMassa and Matthew Holt had Mike on to discuss Code Blue — his magnum opus on how the American system become the medical-industrial complex that it is, the part he played, and what we might do to fix it! A fascinating and rich discussion. (Source: The Health Care Blog)
Source: The Health Care Blog - October 22, 2020 Category: Consumer Health News Authors: matthew holt Tags: THCB Book Club THCB Spotlights Code Blue Jessica DaMassa Matthew Holt Medical Industrial Complex Mike Magee Viagra Source Type: blogs
COVID-19 Vaccines Depend on Globalization (And, Therefore, So Does the Trump Administration)
Scott LincicomeLast week, theWall Street Journalexamined government efforts to secure early access to doses of the most advanced COVID-19 vaccines, and how this access could prove to be a game‐changer for these economies in 2021. As shown in the following WSJ chart, many governments have contracted with multiple pharmaceutical companies in order to ensure that they have access to at least one vaccine that successfully completes “Phase III” trials, which are now underway for most of the listed drugs. Among these governments is the United States, which has thus far secured vaccine commitments from Oxford/Ast...
Source: Cato-at-liberty - October 12, 2020 Category: American Health Authors: Scott Lincicome Source Type: blogs
For Coronavirus Pandemic Management, In Johnson and Johnson and Pfizer Trump Trusts: Public Health at Risk ... Due to Corruption?
(Source: Health Care Renewal)
Source: Health Care Renewal - October 4, 2020 Category: Health Management Tags: coronavirus COVID-19 dark money Donald Trump Johnson and Johnson Pfizer revolving doors vaccines Source Type: blogs
TWiV 644: Don ’ t let perfect be the enemy of good
In this mid-week edition, identifying flawed research before it becomes dangerous, Michigan governor tells America to mask-up, Pfizer mRNA vaccine gets $1.95 billion from Warp Speed, preliminary phase I/II results of the ChAdOx1 SARS-CoV-2 vaccine, answers to listener questions. Click arrow to playDownload TWiV 644 (69 MB .mp3, 115 min)Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show notes […] (Source: virology blog)
Source: virology blog - July 23, 2020 Category: Virology Authors: Vincent Racaniello Tags: Uncategorized ChAdOx1 COVID-19 face mask pandemic Pfizer mRNA vaccine SARS-CoV-2 viral virology virus viruses Warp Speed Source Type: blogs
American Businesses Tackle the Coronavirus
Chris EdwardsBusinesses are racing to produce vaccines, treatments, and medical supplies to help slow and ultimately defeat the pandemic. Companies are ramping up output of safety equipment and ventilators, creating improved tests, working on vaccines, and developing treatments for covid ‐19.There is much dismal news these days, so it is heartening to read about the rapid and concerted actions taken by entrepreneurs and businesses on every facet of the crisis.Here is some of the progress American firms are making:EO Products started increasing production of its hand sanitizer brand in January and is now pumping out 16...
Source: Cato-at-liberty - March 24, 2020 Category: American Health Authors: Chris Edwards Source Type: blogs
Fitbit Health Solutions: Interview with Amy McDonough, GM and Senior VP
FitBit, a well know maker of wearable devices, is rapidly expanding into data-oriented health solution services. That was an overarching theme in our conversation with Amy McDonough, General Manager and Senior Vice President for Fitbit Health Solutions. She sat down with us recently to tell us about the company’s offerings and how its solutions improve outcomes and decrease healthcare costs for consumers, employers, and insurance companies. The following is a description of our conversation with Ms. McDonough, taken from notes of the meeting, supplemented by additional information from the company.
Amy McDonough, ...
Source: Medgadget - February 6, 2020 Category: Medical Devices Authors: Medgadget Editors Tags: Cardiology Exclusive Sports Medicine Source Type: blogs
American Lung Association's Lies About E-Cigarettes are Dangerous and Irresponsible
Earlier this week, I revealed that, ironically, in a campaign attacking e-cigarette companies for lying to the public, the American Heart Association was itselflying to the public by asserting that e-cigarettes cannot help smokers quit.Today I reveal that, not to be outdone, the American Lung Association is lying even more blatantly to the public and in a way that is not only irresponsible but dangerous for the public ' s health.In apress release issued yesterday, the American Lung Association made the following claims:Cigarette smoking is no more hazardous than using e-cigarettes.E-cigarettes cannot help smokers quit.If y...
Source: The Rest of the Story: Tobacco News Analysis and Commentary - December 5, 2019 Category: Addiction Source Type: blogs
The Evolution of " Wearable Health Ecosystems " and Associated Partnerships
I am coming to understand that various types of"wearable health ecosystems" (i.e., wearable business models) are evolving. This is an important step in the creation of consumer-facing, healthcare/wellness systems. The latest example is that of Fitbit partnering with pharmaceutical companies (see:Fitbit collaborating with pharma giants Bristol-Myers Squibb and Pfizer). Below is an excerpt from this article:Fitbit and pharmaceutical giants Bristol-Myers Squibb and Pfizer have inked a multiyear partnership to accelerate the detection and diagnosis of atrial fibrillation to reduce the risk of life-threatening e...
Source: Lab Soft News - October 31, 2019 Category: Laboratory Medicine Authors: Bruce Friedman Tags: Diagnostics Health Wearable Healthcare Information Technology Healthcare Innovations Public Health Telemedicine Test Kits and Home Testing Source Type: blogs
American Lung Association Condemns 2.5 Million Ex-Smokers for Using E-Cigarettes to Quit
What do you say to a person who smoked two packs of cigarettes per day for 30 years and then quits completely by switching to vaping?I would say: Congratulations on this amazing and difficult accomplishment. You ' ve saved your life and done a huge service not only to yourself but to your family and friends.The American Lung Association, in contrast, is saying to vapers: Shame on you! You shouldn ' t have done that. You ' re a bad person because you ' re still using a tobacco product. And you ' re at risk of dying from acute respiratory failure.Specifically, the American Lung Associationstated: " The bottom line is that e-...
Source: The Rest of the Story: Tobacco News Analysis and Commentary - September 1, 2019 Category: Addiction Source Type: blogs
How Much Is Life Worth?
Multivitamins, drugs, gene therapies, human skin, heart, eyeballs, kidneys, entire dead bodies – everything comes with a price tag. Putting aside the moral questions of why and how come that the capitalist market priced even our body parts and health, we asked the question of how much is life worth: what is the maximum that you would/should pay for a life-saving drug? How high is too high a cost if a drug can save 200-300 babies a year from debilitating illness or death? And ultimately, does the pricing of new technologies, especially gene therapies, enable to fulfill their promise?
There’s a
price for everything: ...
Source: The Medical Futurist - August 31, 2019 Category: Information Technology Authors: nora Tags: Bioethics Biotechnology Future of Pharma Genomics cost daraprim drug drug price Gene gene therapy genetics insulin life medication pricing policy rare disease rare disorder Source Type: blogs
Fight Aging! Newsletter, August 19th 2019
In conclusion, our data show how oncogenic and tumor-suppressive drivers of cellular senescence act to regulate surveillance processes that can be circumvented to enable SnCs to elude immune recognition but can be reversed by cell surface-targeted interventions to purge the SnCs that persist in vitro and in patients. Since eliminating SnCs can prevent tumor progression, delay the onset of degenerative diseases, and restore fitness; since NKG2D-Ls are not widely expressed in healthy human tissues and NKG2D-L shedding is an evasion mechanism also employed by tumor cells; and since increasing numbers of B cells express NKG2D ...
Source: Fight Aging! - August 18, 2019 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Jim Mellon Interviewed by Adam Ford at Undoing Aging 2019
Adam Ford of Science, Technology, and the Future carried out a number of interviews while at Undoing Aging in Berlin earlier this year. The interview materials are steadily being processed and uploaded, and that just recently included this interview with Jim Mellon, billionaire investor and philanthropist, cofounder of Juvenescence, and a very down to earth fellow who is interested in improving the human condition by targeting aging with new biotechnologies. Accordingly, he has used his resources to put himself into a position to talk up the longevity industry, move research forward, and attract a great deal more funding f...
Source: Fight Aging! - August 12, 2019 Category: Research Authors: Reason Tags: Healthy Life Extension Community Source Type: blogs
